Form 8-K - Current report:
SEC Accession No. 0001558370-21-000329
Filing Date
2021-01-21
Accepted
2021-01-21 17:03:11
Documents
6
Period of Report
2021-01-18
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 3.02: Unregistered Sales of Equity Securities
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K tmb-20210118x8k.htm 8-K 41487
2 EX-4.1 tmb-20210118xex4d1.htm EX-4.1 126195
3 EX-10.1 tmb-20210118xex10d1.htm EX-10.1 273688
4 EX-10.2 tmb-20210118xex10d2.htm EX-10.2 187418
5 EX-99.1 tmb-20210118xex99d1.htm EX-99.1 18883
6 EX-99.2 tmb-20210118xex99d2.htm EX-99.2 10998
  Complete submission text file 0001558370-21-000329.txt   659984
Mailing Address 200 BERKELEY ST. FL 19 BOSTON MA 02116
Business Address 200 BERKELEY ST. FL 19 BOSTON MA 02116 (857) 702-9600
NeuroBo Pharmaceuticals, Inc. (Filer) CIK: 0001638287 (see all company filings)

EIN.: 472389984 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37809 | Film No.: 21542752
SIC: 2834 Pharmaceutical Preparations